Answers are grounded in this paper and cite their sources.
Diabetic nephropathy (DN) is a major complication occurring in type 2 diabetic(T2DM) patients and characterized by persistent albuminuria and decreased renal function.Microalbuminuria (MAU) is a well-known early marker of DN in T2DM patients.This study aimed to analyse the possible associations among glycated hemoglobin (HbA1c), daily vitamin C(ascorbic acid) intake, and urinary microalbumin, as predictors of DN in T2DM patients.The cross-sectional study was utilized to analyze the secondary data from the National Health and Nutrition Examination Survey.The study population comprised 510 patients who were not diagnosed with hypertension prior to T2DM.Statistical analysis was done by using R 3.5.1 version and this study analyzed by simple linear and stepwise multiple regression.Among patients with T2DM, 19.0% had MAU, 75.7% had nomoalbuminuria, and 5.3% had macroalbuminuria.The value of HbA1c was significantly higher in patients with MAU and macroalbuminuria than in normoalbuminuria.As a result of the study, microalbuminuria was predicted by HbA1c and there was an interaction between daily vitamin C intake and HbA1c.This means that microalbuminuria is a risk marker for DN and is associated with HbA1c and vitamin C. Therefore, in type 2 diabetic patients, periodic screening of blood glucose and high-dose vitamin C intake are required for preventing MAU and DN.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: